These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 3735692)
1. [Hereditary methemoglobinemia due to NADH cytochrome b5 abnormality--clinical importance of the enzyme in leukocytes and platelets]. Tomita Y; Inagaki M; Taki M; Miura T; Saito N; Meguro T; Yamada K; Fujii H; Takizawa T; Miwa S Rinsho Ketsueki; 1986 Mar; 27(3):412-9. PubMed ID: 3735692 [No Abstract] [Full Text] [Related]
2. Alteration of NADH-diaphorase and cytochrome b5 reductase activities of erythrocytes, platelets, and leucocytes in hereditary methaemoglobinaemia with and without mental retardation. Takeshita M; Matsuki T; Tanishima K; Yubisui T; Yoneyama Y; Kurata K; Hara N; Igarashi T J Med Genet; 1982 Jun; 19(3):204-9. PubMed ID: 6896729 [TBL] [Abstract][Full Text] [Related]
3. [Cell differentiation, maturation and enzyme abnormality--studies on NADH-cytochrome b5 reductase]. Takeshita M; Yubisui T Rinsho Ketsueki; 1986 Jul; 27(7):1138-44. PubMed ID: 3783996 [No Abstract] [Full Text] [Related]
5. [Clinical significance of cytochrome b5 reductase analysis in blood cell chemical tests]. Takeshita M Nihon Rinsho; 1989 Dec; 48 Suppl():982-4. PubMed ID: 2622040 [No Abstract] [Full Text] [Related]
6. NADH-cytochrome b5 reductase in platelets and leukocytes with special reference to normal levels and to levels in carriers of hereditary methemoglobinemia with or without neurological symptoms. Tanishima K; Matsuki T; Fukuda N; Takeshita M; Yoneyama Y Acta Haematol; 1980; 63(1):7-12. PubMed ID: 6768212 [TBL] [Abstract][Full Text] [Related]
7. [Hereditary methemoglobinemia with mental retardation and neurologic disorders. Clinical and biochemical study of a case]. Beauvais P; Leroux A; Kaplan JC Nouv Presse Med; 1976 Dec; 5(41):2793-5. PubMed ID: 995609 [No Abstract] [Full Text] [Related]
8. [Leu 72 Pro mutation in the NADH-cytochrome b5 reductase gene found in a Chinese hereditary methemoglobinemia patient]. Wu Y; Huang C; Zhu Z Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):195-7. PubMed ID: 11243135 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and biological forms of cytochrome b5 reductase deficiency]. Kaplan JC; Leroux A; Beauvais P C R Seances Soc Biol Fil; 1979; 173(2):368-79. PubMed ID: 159760 [TBL] [Abstract][Full Text] [Related]
10. Structural analysis of NADH-cytochrome b5 reductase in relation to hereditary methemoglobinemia. Yubisui T; Murakami K; Shirabe K; Takeshita M; Zenno S; Tomatsu S; Fukumaki Y Prog Clin Biol Res; 1989; 319():107-19; discussion 120-1. PubMed ID: 2695933 [No Abstract] [Full Text] [Related]
17. Concentration of NADH-cytochrome b5 reductase in erythrocytes of normal and methemoglobinemic individuals measured with a quantitative radioimmunoblotting assay. Borgese N; Pietrini G; Gaetani S J Clin Invest; 1987 Nov; 80(5):1296-302. PubMed ID: 3680497 [TBL] [Abstract][Full Text] [Related]
18. New variant of cytochrome b5 reductase deficiency (b5RKurashiki) in red cells, platelets, lymphocytes, and cultured fibroblasts with congenital methemoglobinemia, mental and neurological retardation, and skeletal anomalies. Yawata Y; Ding L; Tanishima K; Tomoda A Am J Hematol; 1992 Aug; 40(4):299-305. PubMed ID: 1503085 [TBL] [Abstract][Full Text] [Related]